DE:NTK1 Stock Latest News
Company AnnouncementsGlycotest secures key MUSC biomarker licence to bolster liver fibrosis diagnostics2w ago
Company AnnouncementsEMV Capital lifts NAV as portfolio matures and platform scales1M ago
Company AnnouncementsEMV Capital Sets Date for Interim Results and Investor Presentation1M ago
Company AnnouncementsEMV Capital Acquires Rotterdam Plastics Recycling Plant for Venture Build Expansion1M ago
Company AnnouncementsEMV Capital to spotlight AMR Bio and ProAxsis in investor portfolio showcase3M ago
Company AnnouncementsEMV Capital reshapes Glycotest and ProAxsis stakes as portfolio shifts to associate model4M ago
Company AnnouncementsEMV Capital’s AMR Bio pushes XF-73 antimicrobial towards Phase 3 in major infection markets5M ago
Company AnnouncementsEMV Capital narrows losses as assets under management climb and venture portfolio gains traction5M ago- Company AnnouncementsEMV Capital Launches Phantom Carry Scheme to Align Leadership with Investor Returns5M ago
- Company AnnouncementsEMV Capital Sets Date for 2025 Final Results and Investor Presentation5M ago
Company AnnouncementsEMV Capital to Spotlight Vortex and DName-iT in Investor Portfolio Event8M agoCompany AnnouncementsEMV Capital Lifts AUM Past £100m as Venture Platform and Portfolio Deliver in 20259M ago
Company AnnouncementsEMV Capital Discloses PDMR Share Transfer with No Change in Beneficial Holding9M ago
Company AnnouncementsEMV Capital-backed Sofant Secures £6.25m to Pivot from R&D to Commercial Rollout10M ago
Company AnnouncementsEMV Capital Discloses Director’s Internal Share Transfer With Holding Unchanged10M ago
Company AnnouncementsWanda Health Secures £0.86 Million to Boost US Expansion10M ago
Company AnnouncementsEMV Capital Issues New Shares to Directors, Boosting Market Confidence10M ago
Company AnnouncementsEMV Capital Expands Finance Leadership to Support Growth11M ago